Literature DB >> 21526049

Percutaneous approach to treatment of coronary disease in a patient with uremic cardiomyopathy.

Gianluca Petrillo1, Plinio Cirillo, Maria Prastaro, Greta Luana D'Ascoli, Federico Piscione.   

Abstract

Uremic cardiomyopathy is chronic ischemic left ventricular dysfunction characterized by heart failure, myocardial ischemia, hypotension in dialysis and arrhythmia. This nosologic entity represents a leading cause of morbidity and mortality among patients with end-stage renal disease receiving long-term hemodialysis. It is intuitive that revascularization in the presence of coronary artery disease in these patients represents an effective option for improving their prognosis. Although the surgical option seems to be followed by the best clinical outcome, some patients refuse this option and others are not good candidates for surgery. The present report describes the case of a patient affected by uremic cardiomyopathy and severe coronary artery disease in whom revascularization with percutaneous coronary angioplasty was followed by a significant improvement in quality of life.

Entities:  

Keywords:  Coronary artery disease; Heart failure; Percutaneous coronary intervention; Uremic cardiomyopathy

Year:  2011        PMID: 21526049      PMCID: PMC3082735          DOI: 10.4330/wjc.v3.i4.117

Source DB:  PubMed          Journal:  World J Cardiol


  10 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

Authors:  Kim A Eagle; Robert A Guyton; Ravin Davidoff; Fred H Edwards; Gordon A Ewy; Timothy J Gardner; James C Hart; Howard C Herrmann; L David Hillis; Adolph M Hutter; Bruce Whitney Lytle; Robert A Marlow; William C Nugent; Thomas A Orszulak; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Joseph P Ornato
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

3.  United States Renal Data System 2008 Annual Data Report.

Authors:  Allan J Collins; Robert N Foley; Charles Herzog; Blanche Chavers; David Gilbertson; Areef Ishani; Bertram Kasiske; Jiannong Liu; Lih-Wen Mau; Marshall McBean; Anne Murray; Wendy St Peter; Haifeng Guo; Qi Li; Shuling Li; Suying Li; Yi Peng; Yang Qiu; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; David Zaun; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2009-01       Impact factor: 8.860

Review 4.  2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven R Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan M Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; Eric D Peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

5.  Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis.

Authors:  Christian Bruch; Markus Rothenburger; Michael Gotzmann; Thomas Wichter; Hans H Scheld; Günter Breithardt; Rainer Gradaus
Journal:  Int J Cardiol       Date:  2006-10-16       Impact factor: 4.164

6.  Outcome and risk factors for left ventricular disorders in chronic uraemia.

Authors:  P S Parfrey; R N Foley; J D Harnett; G M Kent; D C Murray; P E Barre
Journal:  Nephrol Dial Transplant       Date:  1996-07       Impact factor: 5.992

Review 7.  ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  Sharon Ann Hunt
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

8.  Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.

Authors:  Gengo Sunagawa; Tatsuhiko Komiya; Nobushige Tamura; Genichi Sakaguchi; Taira Kobayashi; Takashi Murashita
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

Review 9.  Optimal method of coronary revascularization in patients receiving dialysis: systematic review.

Authors:  Immaculate F Nevis; Anna Mathew; Richard J Novick; Chirag R Parikh; Philip J Devereaux; Madhu K Natarajan; Arthur V Iansavichus; Meaghan S Cuerden; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

10.  Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population.

Authors:  Germano Di Sciascio; Giuseppe Patti; Andrea D'Ambrosio; Annunziata Nusca
Journal:  Catheter Cardiovasc Interv       Date:  2003-08       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.